Related Experiment Video
Updated: Sep 8, 2025

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Advances in chitosan-based materials for oral ulcer treatment
Xinying Zhang1, Jiayun Lei2, Tingting Qu3
1Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China; School of Stomatology, the Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266003, China.
None:
Oral ulcers are a prevalent condition globally, causing significant pain and discomfort. The unique environment of the oral cavity, characterized by its humidity and dynamic nature, in conjunction with a diverse microbiome, presents challenges for traditional treatments for oral ulcers. Chitosan has emerged as a promising therapeutic agent for this condition. This review integrates findings from 34 peer-reviewed studies conducted between 2000 and 2025, with a focus on significant chitosan-based formulations. These formulations encompass hydrogel systems, microneedle systems, nanoparticle carriers, oral films, and nanofiber scaffolds. The evidence presented indicates that these chitosan-based materials display greater efficacy compared to conventional alternatives. Nevertheless, certain limitations remain, including transient adhesion, non-selective antimicrobial activity that may disrupt the commensal microbiota, and mechanical instability under the shear forces exerted by saliva. The integration of materials science and precision manufacturing holds the potential to yield next-generation chitosan platforms. In conclusion, this review elucidates the characteristics of oral ulcers, explores the biological activities of chitosan, and examines the diverse range of chitosan-based materials. The objective is to provide researchers and clinicians with valuable insights that can aid in the development and application of novel chitosan-based therapeutic strategies for managing oral ulcers.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Hand hygiene
Hand washing...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

